| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | 0.048 | 0.5 |
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.5 |
| mRNA | triptolide | CTRPv2 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.5 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.02 | 0.5 |
| mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.5 |
| mRNA | HC-067047 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.021 | 0.5 |